Health Technology · Pharmaceuticals: Major · NSE: SAIPARENT · data 2026-10-09

Sai Parenterals Limited

Health check: Average (6.4/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹493.9

Market cap

₹2,210 cr

P/E

—

P/B

—

ROE

4.9%

ROCE

5.8%

Debt / equity

0.96

Dividend yield

0.00%

1-year return

23.5%

52-week high

₹706

52-week low

₹400

Operating margin

—

Growth

Revenue (last 12 months)	—
Net profit (last 12 months)	—
Sales growth, 3 years (yearly)	57.9%
Profit growth, 3 years (yearly)	48.3%

Chart patterns

Double top — forming (key level ₹491.25)

Similar companies

Dishman Carbogen Amcis Ltd. (DCAL) · Venus Remedies Limited (VENUSREM) · Syncom Formulation (India) Ltd. (SYNCOMF) · Sakar Healthcare Ltd (SAKAR) · Indoco Remedies Limited (INDOCO)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open SAIPARENT in NSE Scanner →